Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to [email protected]) ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of opi ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims by state and municipal governments and individuals.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than $7.

Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern District of New York to settle opioid-related claims involving the company for ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of ...

Purdue Pharma has filed a revised bankruptcy plan to finalize a $7.4 billion opioid settlement after the U.S. Supreme Court blocked its previous deal. The plan seeks to resolve lawsuits accusing the ...

Purdue Pharma is seeking approval from a bankruptcy judge for its reorganization plan, which aims to dissolve the company and ...